MYGN

NASDAQ · Equity

Myriad Genetics Inc

US Healthcare Diagnostics & Research

Latest week
29 May 2026
Close
3.970000
Fair value
14.287372
Expectation
Negative 43.01%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
3.97
12-Week Change
-14.81%
Trend Signal
Inactive
Expectation
Negative 43.01%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-44.01
Market Dynamics
0.05

Over the latest 12 completed weeks ending 2026-05-29, MYGN fell 14.81%, moving from 4.66 to 3.97. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -44.01 and has softened across the 12-week window. Market Dynamics is 0.05 on the latest week. Expectation is negative at 43.01%.